Table 1.
Baseline Scores by Treatment Condition
| Measure | PA-CBT (n=16) | AO-CBT (n=8) | χ-value |
|---|---|---|---|
| Adolescent gender | 87.5% female | 75% female | 0.60 |
| Parent gender | 93.8% female | 100% female | 0.52 |
| Adolescent history of attempt | 50% | 0% | — |
| Parent history of attempt | 37.5% | 37.5% | 0.0 |
| Parent current MDE | 87.5% | 75% | 0.60 |
| Adolescent medication at baseline | 68.8% | 50% | 0.80 |
| Parent medication at baseline | 75.0% | 87.5% | 0.51 |
| Adolescent medication end of treatment | 66.7% | 57.1% | 1.47 |
| Parent medication end of treatment | 78.6% | 85.7% | 0.15 |
| Adolescent medication follow-up | 71.4% | 66.7% | 0.05 |
| Parent medication follow-up | 64.3% | 66.7% | 0.01 |
| Measure | PA-CBT (n=16) | AO-CBT (n=8) | t value | Effect size |
|---|---|---|---|---|
| Adolescent age | 14.69 (1.78) | 14.00 (1.69) | 0.91 | 0.40 |
| Parent age | 44.94 (7.48) | 42.25 (8.68) | 0.79 | 0.33 |
| Adolescent BDI | 29.32 (11.76) | 19.13 (5.94) | 2.82** | 1.09 |
| Parent BDI | 28.81 (14.78) | 19.00 (10.04) | 1.86 | 0.78 |
| Adolescent current BSS | 9.81 (7.85) | 5.75 (6.09) | 1.28 | 0.58 |
| Parent current BSS | 4.63 (6.96) | 1.00 (1.85) | 1.95† | 0.71 |
| Adolescent HSC | 9.25 (4.92) | 4.63 (2.77) | 2.45* | 1.16 |
| Parent BHS | 9.69 (5.47) | 5.38 (4.81) | 1.89† | 0.84 |
| Adolescent CDRS | 62.13 (12.78) | 52.38 (10.50) | 1.86† | 0.83 |
| Adolescent MSI-BPD | 6.38 (2.13) | 4.50 (1.41) | 2.25* | 1.04 |
| Parent MSI-BPD | 5.44 (1.86) | 4.00 (2.62) | 1.56 | 0.63 |
| CTQ | 44.50 (14.92) | 42.25 (8.88) | 0.39 | 0.18 |
| Number of sessions adolescents attended | 11.38 (5.98) | 11.88 (6.66) | 0.19 | 0.08 |
| Adolescent number of medications baseline | 1.0 (.82) | 0.88 (.99) | 0.33 | 0.14 |
| Parent number of medications baseline | 1.25 (1.0) | 1.25 (.89) | 0 | 0 |
| Adolescent number of medications end of treatment | 1.13 (1.06) | 1.14 (1.07) | 0.02 | 0.01 |
| Parent number of medications end of treatment | 1.21 (.89) | 1.0 (.58) | 0.57 | 0.28 |
| Adolescent number of medications follow-up | 1.0 (.78) | 1.0 (.89) | 0 | 0 |
| Parent number of medications follow-up | 1.36 (1.34) | 0.60 (.55) | 1.21 | 0.75 |
The measure of effect size used was Cohen's d. Size estimates recommended by Cohen (1988) are: small, 0.2; medium, 0.5; and large, 0.8. End of treatment medication data include (n=22) adolescents and (n=21) parents; follow-up medication include (n=20) adolescents and (n=20) parents.
p<0.05, **p=0.01, †p<0.10.
AO-CBT, adolescent only cognitive behavioral therapy condition; PA- CBT, parent and adolescent concurrent cognitive behavioral therapy condition; MDE, major depressive episode; BDI, Beck Depression Inventory; BSS, Beck Suicide Scale; HSC, Hopelessness Scale for Children; BHS, Beck Hopelessness Scale; CDRS, Children's Depression Rating Scale; MSI-BPD, McLean Screening Instrument for Borderline Personality Disorder; CTQ, Childhood Trauma Questionnaire.